(lp0
S"Dynavax Technologies Corporation  Looks Like A PDUFA Winner Insider Financial - Mar 2, 2017 One such opportunity lies in Dynavax Technologies Corporation . This is a stock that traders love to hate. For the past twelve months and more, it's been repeatedly beaten down based on a drawn out approval pathway for its lead hepatitis B&nbsp;...Did Market Over-React to FDA News on Dynavax Technologies Corporation (NASDAQ ... - StockNewsUnion"
p1
aS"Dynavax Technologies Corporation  Shares Jump on NDA Acceptance Smarter Analyst - Feb 28, 2017 Dynavax Technologies Corporation  investors cheer the news that the FDA has accepted for review Dynavax's responses to the Complete Response Letter  issued by the FDA in November 2016 for the Biologics License Application for&nbsp;...Price Mover of Last Trading Day: Dynavax Technologies Corporation  - Is storiesDynavax Announces FDA Acceptance for Review of Its Complete Response to ... - Marketwired "
p2
aS"Dynavax Technologies Corporation  hit its 52 Week low of $3.2 on Nov 14 ... The Newburgh Press - 18 hours ago Here, 1 indicates a Strong Buy and 5 indicates a Strong Sell. Considering the performance, Dynavax Technologies Corporation 's shares have the potential to reach a high EPS of -0.42 per share, and a low EPS of -0.68 per share in the current quarter.Looking at the Levels for Dynavax Technologies Corporation  - The StandardDynavax Technologies  Reaches $5.95 After 8.00% Down Move; Timmins Gold ... - Herald KS"
p3
aS'Stock Update : Dynavax Technologies Corporation Reports 4Q and ... Smarter Analyst - Mar 13, 2017 Dynavax Technologies Corporation  reported financial results for the fourth quarter and year ended December 31, 2016.'
p4
aS'Dynavax: A Wee Glimmer Of Hope Seeking Alpha - Mar 3, 2017 Dynavax stalwarts had been throwing in so many towels that there were few left to throw. So great was the despair that the teeniest bit of good news rocketed the stock upwards.'
p5
aS"Dynavax Technologies Corporation  Presents Clinical Data from SD-101 at ... Smarter Analyst - Mar 6, 2017 Dynavax Technologies Corporation  announced the presentation of findings in patients with metastatic melanoma in the dose escalation phase of an ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist,&nbsp;...UPDATE: Dynavax shares reverse premarket losses to open flat - MarketWatch"
p6
aS'Inspecting more closely technicals of Dynavax Technologies Corporation  USA Commerce Daily - 16 hours ago With all other things going on, Dynavax Technologies Corporation  has been on a run - rising 49.38 percent in just three months.'
p7
aS'Dynavax In 2017: Hero Or Zero? Seeking Alpha - Jan 18, 2017 The deeper I have gone into the Dynavax story, the more I have come to believe that its own recurring failures are the author of its current unhappy situation.'
p8
aS"What Analysts are Predicting For Lattice Semiconductor Corporation (LSCC ... The USA Commerce - Mar 24, 2017 Shares of Lattice Semiconductor Corporation  dropped -1.26% to $7.04. During the trading on 03/23/2017, Company's stock ranged from $7.12 to $7.01."
p9
aS'Dynavax Technologies Corporation  Quant Investor Update Business Review - Mar 27, 2017 Dynavax Technologies Corporation  currently has a Q.i. Value of 75.00000. Checking in on some valuation rankings, Dynavax Technologies Corporation  has a Value Composite score of 92. Developed by James&nbsp;...'
p10
a.